Search PubMed⌕ Search

Biomedical subjects

J Sany

Publications and source records attributed to J Sany.

At least 145 records · Page 8Linked to original sources

Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease.

In order to clarify the mechanisms involved in the occurrence of lytic bone lesions (BL) in multiple myeloma (MM), we have compared the presenting myeloma-induced histological bone changes of 14 previously untreated MM patients with lytic BL with those of seven MM patients lacking lytic BL at presentation despite similar myeloma cell mass. A major unbalanced bone remodeling (increased bone resorption with normal to low bone formation) was the characteristic feature of patients presenting lytic BL. Furthermore, this unbalanced process was associated with a significant reduction of bone mass. Unexpectedly, a balanced bone remodeling (increase of both bone resorption and bone formation, without bone mass reduction) rather than a true lack of an excessive bone resorption was the usual feature of patients lacking lytic BL. Our current work clearly shows that a majority (72%) of patients with MM present an important unbalanced bone remodeling at diagnosis, leading to bone mass reduction and bone destruction (unbalanced MM). Some patients (20%) retain a balanced bone remodeling with initial absence of bone destruction (balanced MM). Few (8%) patients have pure osteoblastic MM without bone destruction.

Bone Diseases↗

Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.

Antibodies to Sm and RNP antigens have been detected by immunoblotting and immunoprecipitation of small nuclear ribonucleoproteins in 168 sera from patients with connective tissue diseases previously characterized by immunodiffusion. Anti-RNP and anti-Sm antibodies immunoprecipitated U1 and U1-U6 snRNA respectively. By immunoblotting anti-Sm reacted with B-B' and D polypeptides and we have distinguished two types of anti-RNP sera: 1) 'full spectrum' anti-RNP sera reacted with the 68 kD, A, C and B-B' polypeptides; 2) 'partially reactive' anti-RNP sera reacted with various combinations of these polypeptides but not the four of them. A strong specificity of anti-Sm antibodies for systemic lupus erythematosus (SLE) was found with all three methods but immunoblotting was more sensitive and detected anti-Sm in 76% of SLE sera. Sera containing a high titer of 'full spectrum' anti-RNP without anti-Sm activity were only detected in mixed connective tissue disease (MCTD) whereas anti-68 kD antibodies alone seemed to be less specific. This strong association between 'full spectrum' anti-RNP antibodies and MCTD supports the hypothesis that MCTD is a distinct clinical entity associated with a specific serologic marker.

Autoantibodies↗

Increase of class II HLA molecules on the membrane of B lymphocytes from patients with rheumatoid arthritis.

Using a novel cytofluorometric method of cellular antigen quantification, we examined peripheral blood mononuclear cells (PBMC) from patients suffering from rheumatoid arthritis (RA) for quantitative modification of class II human leucocyte antigen (HLA) molecules expressed on the surface. Class II HLA molecules were detected by indirect immunofluorescence with a monomorphic monoclonal antibody. No change was observed in the density of class II HLA molecules at the surface of monocytes of RA patients as compared to that of paired healthy subjects. We confirmed that the percentage of class II HLA-bearing T cells was slightly increased in RA patients versus controls, but the density of class II antigens per cell could not be determined accurately. An increase in the density of class II HLA molecules on RA B cells was shown, suggesting that a chronic activation stage of this population contributes to the disease.

Antigens, Surface↗

Rheumatoid nodulosis: report of two new cases and discussion of diagnostic criteria.

Two patients with typical rheumatoid nodulosis are described and compared with 24 reported cases. Rheumatoid nodulosis is a particular variant of rheumatoid arthritis associated with palindromic rheumatism, subcutaneous rheumatoid nodules, mild or no systemic manifestation and a benign clinical course. Positive rheumatoid factor and radiologic subchondral bone cysts are usual, but their absence should not eliminate the diagnosis of rheumatoid nodulosis, particularly at the onset of the disease.

Adult↗

[Prediction of the response to basic treatment in rheumatoid polyarthritis. Retrospective study apropos of 140 patients].

In order to isolate prognostic factors of the response to basic treatment in the course of rheumatoid arthritis (RA), the authors are comparing, within the scope of a retrospective study of 140 patients, the initial clinical, biological and radiological characteristics of two populations of 70 "responding" and "non responding" patients at the end of a mean course of 48.8 months. As there are significantly more males in the "responding" group, two different statistical studies are conducted for male and female patients. The first stage of the analysis enables to select a certain number of average variables or of very different distribution between "responding" and "non responding". The second stage enables, with the help of these variables, to conduct an analysis of the main components: a satisfactory discrimination between "responding and non responding" may thus be obtained for male patients; this is not confirmed for female patients, probably because this population is heterogeneous. The last stage consists in a discriminating, step-by-step ascending analysis conducted on the male population; a discriminating function is then established, permitting to differentiate correctly 82 p. cent of the patients between "responding" and "non responding". Finally, a prognostic index, easier to use, is also established, using five discriminating variables for male patients, permitting to differentiate correctly 87 p. cent of the patients.

Anti-Inflammatory Agents↗

[Treatment of rheumatoid arthritis. Comparative study of the effect of immunoglobulins G eluted from the placenta and of venoglobulins].

A double-blind multicenter study comparing the effect of placenta eluted IgG and venoglobulins in the treatment of rheumatoid arthritis was conducted in 113 hospitalized patients. Rheumatoid arthritis was severe, classical (92 cases) or definite (21 cases), seropositive in 87 cases, with nodules in 32 cases; the mean duration of the disease was 10 years. The majority of patients had previously received numerous slow-acting drugs without result or with side-effects. A statistically significant decrease of all the quantitative indices but one (grip strength) was obtained with both products on the 8th day of treatment; the effect of placenta eluted IgG was statistically superior for the number of swollen joints (P less than 0.025), Ritchie's index (P less than 0.0005) and some extra-articular manifestations. There was no significant decrease in associated treatments and biological parameters (erythrocyte sedimentation rate, rheumatoid factor). Tolerance was excellent; some cases of benign venulitis were observed; treatment was never discontinued on account of side-effects. Further placebo-controlled of each of these immunoglobulins of placental origin are needed for firm conclusions to be drawn.

Arthritis, Rheumatoid↗

[What is the role of Epstein-Barr virus in the pathogenesis of connective tissue diseases?].

In rheumatoid arthritis (RA) abnormalities of T suppressive/cytotoxic responses to Epstein-Barr virus (EBV) have been reported: lack of inhibition of spontaneous proliferation of autologous B lymphocytes infected by EBV, lack of late suppression of immunoglobulin secretion induced in vitro by EBV. Moreover, a cross-reaction between EBNA antigen (Epstein Barr Nuclear Antigen) and a cytoplasmic protein of 62 KD present in the rheumatoid synovitis has been described. In primary Sjögren's syndrome, EBV genome has been observed in the parotid of some patients. The abnormalities of T suppressive/cytotoxic responses observed in rheumatoid arthritis are inconstant and non specific; they are noted in some cases of systemic scleroderma and lupus; they remain for a given patient and could be the marker of a particular subset of connective tissue diseases. The pathophysiological role of EBV infection, especially in rheumatoid arthritis and Sjögren's syndrome, remains to be determined.

Antibodies, Viral↗